Daily Briefing

Around the nation: HHS recommends classifying marijuana as a Schedule III substance


HHS has recommended that marijuana be reclassified from a Schedule I to a Schedule III substance under the Controlled Substances Act (CSA), in today's bite-sized hospital and health industry news from Washington, the District of Columbia, and Nationwide.

  • California: Amir Dan Rubin, CEO of One Medical, has announced his departure from the company a year after Amazon acquired it for approximately $3.9 billion. Neil Lindsay, the head of Amazon Health Services, announced Rubin's exit and that Trent Green, One Medical's operating chief, will replace Rubin. In a memo to employees, Rubin wrote that Green "is such a highly effective, experienced, and values-driven leader. I am so excited about all that One Medical is positioned to do going forward as a part of Amazon." (Palmer, CNBC, 9/1)
  • District of Columbia: HHS has recommended that the Drug Enforcement Administration significantly loosen federal restrictions on marijuana, suggesting shifting marijuana from being a Schedule I to a Schedule III substance under the CSA. The recommendation emerges from a review conducted by FDA. HHS' proposal could help resolve many conflicts between federal and state laws, particularly the financial hardships faced by legal cannabis businesses due to their ineligibility for standard business tax exemptions. Critics argue that rescheduling would not fully address issues surrounding criminalization of marijuana possession. DEA will now initiate its review, although it is not obligated to follow the HHS' recommendation. (Fertig/Demko, Politico, 8/30)
  • Georgia: Following a series of fatal incidents primarily in the Northeast and Gulf Coast, CDC has issued a warning to healthcare practitioners across the country to suspect Vibrio vulnificus in infected wounds, especially those exposed to coastal waters during warm sea surface temperatures. There has been a notable expansion in the bacteria's geographic range due to climate change, leading to a roughly eight-fold increase in wound infections between 1988 and 2018. A swift response is crucial to prevent severe health outcomes as V. vulnificus can rapidly progress to necrosis and has resulted in fatalities within 48 hours of exposure. CDC emphasized the importance of early antibiotic therapy and surgical intervention. Additionally, the public is advised to avoid exposure of open wounds to salt and brackish water and seek immediate medical care if an infection occurs. (Fiore, MedPage Today, 9/5)

SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.